About Us — memios
About memios

Built from
lived experience.
Backed by science.

memios was founded after a melanoma diagnosis, a father's battle with Multiple Myeloma and Amyloidosis, and walking alongside a best friend through Stage IV Melanoma. This platform was not built in a boardroom. It was built by people who know what it means to sit in an oncologist's office and wonder what you can do to fight back.

Our founding story

The gap was personal
before it was professional.

Andrew Wilson was 55 when he received his melanoma diagnosis in 2022. His father lost his fight with Multiple Myeloma and Amyloidosis in 2018. His best friend is currently at the end of his fight with Stage IV Melanoma. In the middle of all of it, Andrew kept asking the same question: what can exercise actually do for people going through this?

The answer — documented in over 2,800 randomized controlled trials[1,2] — was remarkable. Exercise reduces cancer-related fatigue by up to 50 percent.[6] It protects the heart from chemotherapy damage.[8] It preserves muscle mass.[7] It lifts depression and anxiety.[9] For breast, colorectal, and prostate cancer, it is associated with reduced recurrence risk and improved survival.[11]

"The science has been clear for years. Most patients just never hear about it. memios changes that."[3]

Only 15 percent of cancer patients currently receive an exercise referral.[3] 162 American cities of 50,000 or more residents have no exercise oncology program at all.[12] The gap between what science proves and what patients receive is not a knowledge problem. It is an infrastructure problem. memios was built to close that gap.

🎯
Our Mission
To make structured cancer exercise a standard part of care for every cancer patient in the United States — from the day of diagnosis through the rest of their life. ASCO mandates this referral for every cancer patient.[5]
🔬
Grounded in Evidence
Over 2,800 peer-reviewed randomized controlled trials.[1] Guidelines from ASCO, ACSM, the American Cancer Society,[7] and the American Heart Association.[8] We do not claim anything science has not already proven.
🌱
Holistic by Design
Physical fitness. Nutrition. Mental wellness. Sleep. Stress management. Spiritual wellbeing. Social connection. Purpose. The memios platform addresses every dimension of health — because cancer affects every dimension of who you are.[10]
📍
Seattle, Washington
memios is headquartered in Seattle, WA. Our team is distributed across the country, connected by a shared belief that every cancer patient deserves access to what science has proven can help them survive — and thrive.[11]
The science behind memios

What the research actually shows.

These are peer-reviewed outcomes from 2,800+ clinical trials, endorsed by every major oncology guideline body. They are the reason memios exists.

2,800+
Randomized Controlled Trials
Every major cancer type, every treatment modality, every phase of care — documenting the clinical benefits of structured exercise.[1,2]
50%
Fatigue Reduction
Cancer-related fatigue — the most disabling side effect of treatment — reduced by up to 50% with structured exercise, outperforming every pharmaceutical intervention studied.[6]
−31%
Reduced Cancer Mortality
Post-diagnosis physical activity linked to 31% reduced cancer-specific mortality, 22% lower recurrence, and 45% lower all-cause mortality in breast cancer survivorship.[11]
15%
Current Referral Rate
Only 15% of cancer patients receive an exercise referral despite ASCO guidelines mandating referral for all patients receiving curative-intent treatment.[3,5]
Leadership

Management Team

The people driving the memios mission — connecting clinical evidence to operational infrastructure, professional certification, and platform technology.

Chief Medical Officer
Dr. Jay Harness
Chief Medical Officer

Dr. Jay K. Harness, MD, FACS is a board-certified surgical oncologist, emeritus breast surgeon, and one of the country's foremost advocates for exercise oncology as a standard of cancer care. He served as Clinical Professor of Surgery at the University of California, Irvine and spent 28 years in full-time academic surgery at the University of Michigan, Tufts University, and the University of California system.

Dr. Harness is the founder of Cancer Fitness and Chief Medical Officer at Maple Tree Cancer Alliance. He is Past-President of the American Society of Breast Surgeons, the American Association of Endocrine Surgeons, and Breast Surgery International. He has authored over 100 scientific articles, 30 book chapters, and edited four medical textbooks. He co-chairs the ISEO Communications Committee and serves on the co-chair panel for exercise oncology policy advocacy — work directly aligned with the ASCO referral mandate[5] and NAPBC 2024 documentation standards.[18]

MD, FACS — University of Michigan Medical Center
LinkedIn ↗
Chief Marketing Officer
Greg Hendrickson
Chief Marketing Officer

Gregory Hendrickson brings over 35 years of diverse business experience spanning leadership roles in sales, marketing, product management, and executive strategy across multiple Fortune 1000 companies. He co-founded Path Capital Advisors, a growth and capital advisory service for CEOs and boards of directors, and served as President of EER, Inc.

Greg is the Business Advisor at the Cancer Exercise Training Institute (CETI) — memios's certification partner — where he leads business and marketing training for Cancer Exercise Specialists worldwide. His expertise in building oncology exercise practices and his deep relationships within the CES professional community make him a central architect of the memios go-to-market strategy and the professional network that connects certified specialists to hospital clients.[19]

Kellogg School of Management — Northwestern University
LinkedIn ↗
Chief Executive Officer
Andrew Wilson
Chief Executive Officer & Founder

Andrew Wilson founded memios after his own melanoma diagnosis in 2022, his father's battle with Multiple Myeloma and Amyloidosis, and walking alongside his best friend through Stage IV Melanoma. This platform was not built in a boardroom — it was built from lived experience, deep research into the 2,800+ clinical trials[1] documenting exercise's role in cancer care, and an unwavering belief that every cancer patient deserves access to what science has proven can help them survive and thrive.

A health and wellness advocate on his own journey to live strong and active into his 90s, Andrew brings a founder's urgency to closing the gap between exercise oncology evidence and clinical delivery. He is the creator of the memios platform and co-creator of the Exercise Oncology National Standard model that underpins the hospital licensing program — addressing the reality that only 15% of cancer patients currently receive an exercise referral[3] despite overwhelming evidence and formal ASCO mandate.[5]

Andrew is an Eagle Scout and a Pac-10 Champion on the University of Washington Crew team. He has run a marathon, completed the Seattle to Portland bike ride, climbed Mt. Rainier, and summited two additional peaks in the Cascades. He lives the active life he is building memios to protect.

University of Washington — Seattle, WA — memios.ai
LinkedIn ↗
Advisory Board

Our Advisors

A group of experienced leaders across technology, healthcare, business, and insurance who bring the domain expertise memios needs to build at scale and navigate complex markets.

Business Advisor
Jim DuBois
Business Advisor

Jim DuBois is a board director, senior advisor, speaker, and author with a distinguished record as a technology executive and management consultant. He is best known for serving as Chief Information Officer of Microsoft, where he was responsible for the company's global security, infrastructure, IT messaging, and business applications. He is a Senior Advisor to McKinsey & Co. and a board director at Expeditors, Cyemptive Technologies, Collabra, and Profisee.

Jim brings deep expertise in enterprise technology strategy, scaling digital infrastructure, and building high-performance organizations. His guidance informs the memios technology architecture — including the FHIR R4 platform and EHR integration strategy — our enterprise sales approach to hospital clients, and the operational scaling plan.

Former CIO, Microsoft — McKinsey Senior Advisor
LinkedIn ↗
Business Advisor
Shari Hofer
Business Advisor

Shari Hofer is an executive leader, strategic advisor, and board director with more than two decades of experience driving digital transformation and marketing strategy for major global companies. She served as Executive Vice President and Chief Marketing, Communications, and Sustainability Officer at Wiley, a global leader in publishing, education, and research. She is a board member of Kaiser Foundation Health Plan of Washington and a board member at Voxy.

Based in Seattle, Shari now serves as a strategic advisor to startup organizations and a coach and speaker for caregivers. She holds an Executive Certification in Finance from the University of Chicago Booth School of Business. Her expertise in brand strategy, customer engagement, and healthcare market navigation — including her board-level perspective at Kaiser — is invaluable to memios's payer strategy and growth.

Former EVP CMO, Wiley — Board, Kaiser Foundation Health Plan WA
LinkedIn ↗
Medical Advisor
Dr. Anna Schwartz
Medical Advisor

Dr. Anna L. Schwartz, PhD, FNP-BC, FAAN is one of the most recognized researchers in exercise oncology in the world. She co-chaired the American College of Sports Medicine (ACSM) roundtable that produced the foundational 2010 exercise guidelines for cancer survivors[2] — the document that launched exercise oncology as a clinical discipline. She has been instrumental in establishing the ACSM Cancer and Exercise Trainer certification program and authored The Essentials of Exercise Oncology textbook. Her research has received support from the National Institutes of Health, and she has partnered with the YMCA-USA and LIVESTRONG to develop cancer survivor exercise programs deployed globally.

Dr. Schwartz is the creator of the Cancer Exercise app — a free, research-backed mobile application available on iOS and Android that delivers personalized, evidence-based exercise programs to cancer patients and survivors worldwide. Her 12-week program has demonstrated 51% fatigue reduction, 48% strength improvement, 43% endurance increase, and 60% quality of life improvement[6,10] in clinical use. She is a Fellow of the American Academy of Nursing and recipient of the 2012 Rose Mary Carol Johnson Oncology Nursing Society award.

PhD, FNP-BC, FAAN — cancerexerciseapp.com
LinkedIn ↗
Technical Advisor
Brad Lovering
Technical Advisor

Bradford Lovering is a Distinguished Engineer and veteran of the Pacific Northwest technology community with a career spanning Microsoft, Splunk, SignalSense, and RelationalAI. He spent 24 years at Microsoft, rising to the elite rank of Technical Fellow — a distinction held by fewer than two dozen technologists in the company's history — where he led development on BizTalk Server, Visual Basic, the .NET framework, Visual Studio, and Windows Communication Foundation.

Brad founded the Seattle engineering office for Splunk in 2011 and co-founded SignalSense, a cybersecurity analytics company. He holds a BSEE from the University of Washington. His deep expertise in large-scale data systems, developer platforms, and software architecture directly informs the memios clinical data platform — including the HIPAA-compliant FHIR R4 architecture that tracks FACIT-Fatigue,[6] PROMIS Physical Function,[10] and PHQ-9[9] outcomes at scale.

Former Technical Fellow, Microsoft — Co-Founder, SignalSense
LinkedIn ↗
Insurance Advisor
DJ Wilson
Insurance Advisor

DJ Wilson is a seasoned healthcare policy, insurance, and communications strategist based in Seattle, Washington. He is the founder of Wilson Strategic Communications and has spent his career at the intersection of healthcare strategy, insurance market navigation, and public policy in the Pacific Northwest. He currently serves on the board at Ryther, a behavioral health organization serving children and families.

DJ is author of a leading publication on Washington State healthcare policy and marketplace activity. His deep understanding of health insurance market dynamics, payer relationships, and healthcare policy provides memios with critical strategic guidance as we build our insurance partnership and reimbursement infrastructure — a pathway made more urgent by the pending CMS National Coverage Determination for exercise oncology services.[20,21]

Founder, Wilson Strategic Communications — Seattle, WA
LinkedIn ↗
Medical Advisor
Dr. Jane Yoo
Medical Advisor

Dr. Jane Yoo is a board-certified dermatologist, skin cancer surgeon, and physician-scientist with a unique background spanning clinical medicine, surgical oncology, and health policy. She completed her medical degree from Washington University in St. Louis School of Medicine and served as a NIH-funded physician-scientist on the faculty at the University of Washington for four years, where she studied mechanisms of skin inflammation.

Dr. Yoo is a Fellow of the American Board of Dermatology and currently practices at Frontier Dermatology. She is an active advocate for skin cancer prevention, clinical trial diversity, and evidence-based dermatologic care. Her clinical expertise in skin cancers — including melanoma — and her physician-scientist perspective provide memios with invaluable advisory support on clinical protocol development, oncology care standards, and the integration of exercise oncology with dermatologic and surgical oncology care.

MD — Washington University St. Louis; Former NIH-Funded UW Faculty
LinkedIn ↗
★ Featured Partnership

The Cancer Exercise app —
free, research-backed,
and reaching the world.

Dr. Anna Schwartz created the Cancer Exercise app to make evidence-based exercise programs accessible to every cancer patient and survivor, anywhere in the world, at no cost. Available on iOS and Android, the app delivers personalized programs tailored daily to the user's current physical ability — whether they are three months into treatment or five years into recovery.

The app won two Gold Awards from AVA Digital Awards in 2021 and a Silver Medal for Best Mobile App in 2024. It has received support from the National Institutes of Health and has been deployed in partnership with YMCA-USA and LIVESTRONG globally. This is the kind of reach memios is built to amplify.

Visit cancerexerciseapp.com ↗ Download for iOS Download for Android
51%
Fatigue reduction in 12-week program[6]
48%
Strength improvement over 12 weeks
43%
Endurance increase over 12 weeks
60%
Quality of life improvement[10]
36%
Depression decrease[9]
32%
Anxiety decrease[9]
🆓
Free for all cancer patients and survivors
No cost, no subscription. Available globally on iOS and Android. Designed to remove every barrier between the evidence and the patient.
⚡
Tailored daily — start in under 7 minutes
Programs adapt to daily capacity, cancer type, and treatment phase. Any fitness level. No equipment required to begin.
🌐
NIH-funded research, global deployment
Deployed in partnership with YMCA-USA and LIVESTRONG worldwide. The evidence base includes Dr. Schwartz's ACSM 2010 guideline work.[2]
Join the mission

Every cancer patient
deserves this. Let's build it.

Whether you are a patient looking for support, a professional ready to build a meaningful career, a hospital closing the care gap, or a payer investing in outcomes — memios is ready to partner with you. The evidence is overwhelming.[1] The infrastructure is being built. The moment is now.

For Patients For Professionals For Hospitals Get in Touch

Research References

All statistics and clinical claims on this page are grounded in peer-reviewed research. Numbers in brackets correspond to citations used throughout the page. Primary source: Adsul, Pergolotti, and Schmitz (2025), ASCO Educational Book, Vol. 45, Issue 3, e472854.

1
Campbell KL, Winters-Stone K, Wiskemann J, et al. Exercise guidelines for cancer survivors: consensus statement from international multidisciplinary roundtable. Med Sci Sports Exerc. 2019;51:2375–2390. (2,800+ RCT evidence base; updated ACSM guidelines for all cancer types and treatment phases.)
2
Schmitz KH, Courneya KS, Matthews C, et al. American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc. 2010;42:1409–1426. (First published ACSM guidelines for cancer survivors; 2010 foundation of the field.)
3
Ligibel JA, Pierce LJ, Bender CM, et al. Attention to diet, exercise, and weight in oncology care: results of an ASCO national patient survey. Cancer. 2022;128:2817–2825. (15% referral rate; 90% of oncologists needing more knowledge to refer patients to exercise programs.)
4
American Cancer Society. Cancer Treatment and Survivorship Facts and Figures 2022–2024. Atlanta: American Cancer Society; 2022. (18 million cancer survivors in the US; 2 million+ new diagnoses annually.)
5
Ligibel JA, Bohlke K, May AM, et al. Exercise, diet, and weight management during cancer treatment: ASCO guideline. J Clin Oncol. 2022;40:2491–2507. (ASCO formal mandate that all cancer patients receiving curative-intent treatment should be referred to exercise programming.)
6
Campbell KL et al. (ACSM 2019) and FACIT-Fatigue meta-analyses. Up to 50% reduction in cancer-related fatigue severity. Exercise outperforms all pharmaceutical interventions for cancer-related fatigue. Best-evidenced intervention for chemotherapy-related cognitive impairment (chemobrain).
7
Rock CL, Thomson CA, Sullivan KR, et al. American Cancer Society nutrition and physical activity guideline for cancer survivors. CA Cancer J Clin. 2022;72:230–262. (Resistance training preserves lean body mass; prevents sarcopenia during treatment; nutrition guidelines for cancer survivors.)
8
Gilchrist SC, Barac A, Ades PA, et al. Cardio-oncology rehabilitation to manage cardiovascular outcomes in cancer patients and survivors: a scientific statement from the American Heart Association. Circulation. 2019;139:e997–e1012. (CORE model; cardiotoxic treatment damage; exercise protects cardiovascular function; cardiac rehab CPT 93797-93799.)
9
Campbell KL et al. (ACSM 2019) and PHQ-9/GAD-7 outcomes across exercise oncology RCTs. Exercise reduces depression and anxiety in cancer patients with effectiveness comparable to pharmacological and psychotherapeutic interventions. PHQ-9 used as primary depression screening endpoint.
10
Ligibel JA et al. (ASCO 2022) and FACT-G / PROMIS Global Health meta-analyses. Exercise consistently improves patient-reported quality of life across all cancer types and all treatment phases. PROMIS Physical Function used as primary endpoint in key trials.
11
Rock CL et al. (ACS 2022). Post-diagnosis physical activity linked to 31% reduced cancer-specific mortality, 22% reduced recurrence risk, and 45% reduced all-cause mortality in breast cancer meta-analysis. Similar associations for colorectal and prostate cancer survivorship populations.
12
Schmitz KH, Demanelis K, Crisafio ME, et al. Proximity to cancer rehabilitation and exercise oncology by geography, race, and socioeconomic status. Cancer. 2025;131:e35515. (Landmark geospatial analysis: 162 US cities of 50,000+ with no exercise oncology program; systematic access disparities by geography, race, and income.)
13
Viamonte SG, Joaquim AV, Alves AJ, et al. Cardio-oncology rehabilitation for cancer survivors with high cardiovascular risk: a randomized clinical trial. JAMA Cardiol. 2023;8:1119–1128. (Significant improvement in peak VO2 and quality of life in cardio-oncology rehabilitation RCT.)
14
Giri S, Al-Obaidi M, Weaver A, et al. Association between chronologic age and geriatric assessment–identified impairments in older adults with cancer. J Natl Compr Cancer Netw. 2021;19:922–927. (Geriatric assessment impairments in 61% of patients aged 60–64; muscle mass and physical function as prognosis predictors.)
15
Stout NL, Brown JC, Schwartz AL, et al. An exercise oncology clinical pathway: screening and referral for personalized interventions. Cancer. 2020;126:2750–2758. (Prehabilitation reducing surgical complications; ~32% 30-day readmission reduction; 1.5–2 day LOS reduction.)
16
Winters-Stone KM, Boisvert C, Li F, et al. Delivering exercise medicine to cancer survivors: has COVID-19 shifted the landscape for exercise oncology? Support Care Cancer. 2022;30:1903–1906. (EXCEL study: telehealth delivery; 75%+ self-referral; 80%+ retention in rural/remote populations.)
17
Brennan L, Sheill G, Collier S, et al. Personalised exercise rehabilitation in cancer survivorship: the PERCS triage and referral system study protocol. BMC Cancer. 2024;24:517. (PERCS model; post-procedure rehabilitation; three-tier ORE level assignment; improved adherence and functional outcomes.)
18
National Accreditation Program for Breast Centers (NAPBC). Optimal Resources for Breast Care 2024 Standards. American College of Surgeons, 2025. (Documented exercise recommendation required in medical record for all eligible breast cancer patients under oncology care — effective January 2024.)
19
Schmitz KH, Chongaway A, Saeed A, et al. An initiative to implement a triage and referral system to make exercise and rehabilitation referrals standard of care in oncology. Support Care Cancer. 2024;32:259. (UPMC Hillman Cancer Center EXCEEDS model: 45% patient connection rate using 3–5 minutes of staff time at second chemotherapy infusion.)
20
Kennedy MA, Potiaumpai M, Maitin-Shepard M, et al. Looking back: a review of policy implications for exercise oncology. J Natl Cancer Inst Monogr. 2023:140–148. (Policy review: reimbursement pathway comparison; CMS NCD pathway analysis for exercise oncology services.)
21
Adsul P, Pergolotti M, Schmitz KH. Implementation science as the secret sauce for integrating exercise screening and triage pathways in oncology. Am Soc Clin Oncol Educ Book. 2025;45:e472854. (Primary synthesis: EPIS, CFIR, RE-AIM, ERIC, CaReR frameworks; EXCEEDS, PERCS, CORE, CREST, PGA triage models; CMS NCD submission; full implementation science review.)